How a Simple Non-Covalent Trick is Solving Chemistry’s Toughest Chiral Puzzle (Nature, 2026)

Lausanne, Switzerland: Nishant Shrivastava:

Imagine trying to build a perfect mirror image of a molecule, but with only one hand. That is the daily challenge for synthetic chemists, especially when dealing with fleeting radical intermediates that refuse to follow the rules. A team at EPFL has just revealed a clever workaround that sidesteps decades of design headaches, and it relies on something as simple as two molecules shaking hands without ever forming a permanent bond.

Published in Nature on June 1, 2026, the study introduces a modular platform for enantioselective hydrogen atom transfer (HAT) that does not require building a custom chiral catalyst from scratch. Instead, the researchers let commercially available 2-mercaptopyridines and chiral phosphoric acids (CPAs) self-assemble into dynamic, catalytically active complexes. These assemblies act like tiny chiral cages that selectively grab and release hydrogen atoms during photoredox reactions, a feat that was considered nearly impossible due to the short-lived nature of radical species.

Why does this matter? Over half of all approved drugs contain at least one stereogenic center, and tertiary stereocenters with C(sp³)–H bonds are among the hardest to construct with high enantioselectivity. Traditional methods often require laborious covalent modifications of catalysts, which limits scope and scalability. The new approach flips the script: chemists can now swap CPAs or thiol partners like Lego blocks, rapidly exploring thousands of chiral combinations without resynthesizing entire frameworks.

One of the most striking demonstrations involves the photochemical deracemization of 2-aryl pyrrolidines, core structures in antipsychotics, antidepressants, and neuroprotective agents. Using visible light and the dual function of the non-covalent assembly, the system achieves complete optical enrichment in a single catalytic cycle. Here is how it works: the chiral CPA activates the 2-mercaptopyridine, which selectively abstracts a hydrogen atom from one enantiomer of the racemic substrate. Then, the same chiral complex delivers the hydrogen back in a stereocontrolled manner, converting the minor enantiomer into the major one until equilibrium is reached. It is a molecular relay race where chirality is passed like a baton.

The reaction runs under mild conditions: room temperature, ambient atmosphere, and visible light. It tolerates a wide range of functional groups and sensitive substrates, and the building blocks are inexpensive and readily available. The team validated the system across diverse aryl-substituted heterocycles and nitrogen-containing systems, showing broad applicability beyond the initial test cases.

Mechanistic studies using NMR confirmed that the assembled complex remains stable in solution throughout the catalytic cycle. Kinetic experiments and control tests ruled out background reactions or decomposition, reinforcing that non-covalent interactions are the key to enantiocontrol. And because no metals are involved, concerns about toxicity, cost, and residual contamination vanish, which is a major advantage for pharmaceutical manufacturing.

This work represents a shift from traditional catalyst design. Instead of engineering intricate covalent structures from the ground up, the researchers exploit supramolecular principles to generate chirality dynamically. It mirrors a growing trend in asymmetric catalysis toward adaptive, self-assembling systems that mimic biological processes like enzyme-substrate recognition. The success of this platform opens doors to other radical-mediated transformations, including C–H functionalization, cyclizations, and cascade reactions, that were previously inaccessible under enantioselective conditions.

Beyond pharmaceuticals, the implications reach into agrochemicals, materials science, and fragrances, where chiral purity is essential. The ability to generate enantiopure intermediates efficiently could accelerate drug discovery timelines and reduce environmental impact by minimizing waste and purification steps.

Looking ahead, the research team plans to expand the library of assembling units and investigate the extension of this strategy to other radical types, such as oxygen- and nitrogen-centered radicals. Future work may also focus on immobilizing these assemblies onto solid supports for recyclable catalysis or integrating them into continuous-flow reactors for industrial-scale production.

The publication in Nature underscores the scientific community’s recognition of this methodology as a milestone in asymmetric synthesis. With its simplicity, versatility, and profound mechanistic insight, the non-covalent HAT relay system stands as a beacon for next-generation catalytic strategies, turning molecular cooperation into a powerful tool for creating life-saving medicines with unprecedented precision.